These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11438320)

  • 1. Subcutaneously administered Repronex in oligoovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment.
    Nichols J; Knochenhauer E; Fein SH; Nardi RV; Marshall DC
    Fertil Steril; 2001 Jul; 76(1):58-66. PubMed ID: 11438320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneously administered Repronex in female patients undergoing in vitro fertilization is as effective and well tolerated as intramuscular menotropin treatment. Repronex SC, IVF Study Group.
    Gocial B; Keye WR; Fein SH; Nardi RV
    Fertil Steril; 2000 Jul; 74(1):73-9. PubMed ID: 10899500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneously administered Menopur, a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex in subjects undergoing in vitro fertilization.
    Keye WR; Webster B; Dickey R; Somkuti S; Crain J; Scobey MJ
    Reprod Biol Endocrinol; 2005 Nov; 3():62. PubMed ID: 16280073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous human menopausal gonadotropin administration for controlled ovarian hyperstimulation with intrauterine insemination cycles.
    Kaplan PF; Austin DJ; Freund R
    Am J Obstet Gynecol; 2000 Jun; 182(6):1421-6. PubMed ID: 10871458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
    Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG.
    International Recombinant Human Chorionic Gonadotropin Study Group
    Fertil Steril; 2001 Jun; 75(6):1111-8. PubMed ID: 11384635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of ovarian stimulation and luteal support agents in patients undergoing GnRH antagonist IVF cycles.
    Miller CE; Zbella E; Webster BW; Doody KJ; Bush MR; Collins MG
    J Reprod Med; 2013; 58(3-4):153-60. PubMed ID: 23539885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leuprolide acetate for inducing ovulation in women undergoing ovarian stimulation.
    diDonato P; Nola VF; Pittman TV; Marr V; Stubbs C; Meldrum DR
    J Reprod Med; 1995 Oct; 40(10):715-6. PubMed ID: 8551474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovulation induction and controlled ovarian stimulation using letrozole gonadotropin combination: A single center retrospective cohort study.
    Arya S; Kupesic-Plavsic S; Mulla ZD; Dwivedi AK; Crisp Z; Jose J; Noble LS
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():123-128. PubMed ID: 28985546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of mixed protocols with Bravelle (human-derived FSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization.
    Keye WR; Marrs RP; Check JH; Schnell V; Surrey M; Marshall DC;
    Fertil Steril; 2004 Aug; 82(2):348-57. PubMed ID: 15302283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urofollitropin - Ferring: FERRING hFSH, hFSH - Ferring, human follicle-stimulating hormone - Ferring, Bravelle.
    BioDrugs; 2003; 17(4):288-9. PubMed ID: 12899646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropins.
    Lass A; Vassiliev A; Decosterd G; Warne D; Loumaye E
    Fertil Steril; 2002 Aug; 78(2):265-9. PubMed ID: 12137861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, open, randomized clinical study to assess the efficacy and safety of two gonadotropin preparations administered in WHO Group II anovulatory subfertile women.
    Ernest NH; Flora TO; William SW; Ho PC
    J Obstet Gynaecol Res; 1998 Oct; 24(5):355-61. PubMed ID: 9879155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-beta for in vitro fertilization: a prospective, randomized study.
    Dickey RP; Thornton M; Nichols J; Marshall DC; Fein SH; Nardi RV;
    Fertil Steril; 2002 Jun; 77(6):1202-8. PubMed ID: 12057729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful induction of ovulation and conception with pulsatile intravenous administration of human menopausal gonadotropins in anovulatory infertile women resistant to clomiphene and pulsatile gonadotropin-releasing hormone therapy.
    Ho Yuen B; Pride SM; Sime MO
    Am J Obstet Gynecol; 1984 Mar; 148(5):508-12. PubMed ID: 6422760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized study to assess the clinical efficacy of gonadotrophins administered subcutaneously and intramuscularly.
    Engmann L; Shaker A; White E; Bekir JS; Jacobs HS; Tan SL
    Hum Reprod; 1998 Apr; 13(4):836-40. PubMed ID: 9619533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP).
    Lenton E; Soltan A; Hewitt J; Thomson A; Davies W; Ashraf N; Sharma V; Jenner L; Ledger W; McVeigh E
    Hum Reprod; 2000 May; 15(5):1021-7. PubMed ID: 10783345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
    Duffy DA; Manzi D; Benadiva C; Maier D; Saunders M; Nulsen J
    Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.